PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

Soft-tissue sarcomas (STS) are a group of rare, heterogeneous, and aggressive tumors, with high metastatic risk and relatively few efficient systemic therapies. In the quest for new treatments, the immune system represents an attractive therapeutic target. Recently, PD1/PDL1 inhibitors showed very p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Bertucci, François, Finetti, Pascal, Perrot, Delphine, Leroux, Agnès, Collin, Françoise, Le Cesne, Axel, Coindre, Jean-Michel, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384364/
https://ncbi.nlm.nih.gov/pubmed/28405501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1278100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados